About
MDG

Medgaea Life Sciences is a third party laboratory that is certificated for OECD GLP, TFDA GLP, ISO 17025 and ISO 9001. Maily based on preclinical CRO, we provide total-soltion services to assist biotechnology industries successfully obtain the product certification and exploit internation market.

view more

 

CRO

  • check

    Needs Discuss

  • check

    Quote and Ordar

  • check

    Timetable Schedule

  • check

    Report Launch

  • done

    Case Closed

view more

Services

With devoting to our core value 『Honesty•Accuracy•Professionalism•Responsibility』,

We have successfully assisted our customers to successfully obtain the product certification in FDA, CE, TFDA and NMPA.

Medical Devices

One of the first priority of medical devices R&D is their safety. The Biocompatibility test is mainly followed the ISO 10993 international standard.

Cell therapy and Regenerative medicine

We assist the safety, effectiveness tests during the R&D process of cell therapy product. All the tests are complied with GLP.

Pharmaceutical development

As the agent of SNBL in Taiwan, will help new drugs company to complete non-clinical trials in medium, large animals and primates in the research and development stage.

Agrochemical and Enviromental Agents

The agroculture products need to review their toxicological data in advance, and all the tests must be carried out in complies with GLP.

Chemical Substances

Providing the toxicological test information!
EPA acquired the test information as the core basis to evaluate the substance announcement.

Health Food/ Ingredients

Provide safety, efficacy and stability tests for food ingredients and health foods.

Registration

Provide registration services.

Pharmaceuticals

Provide batch examine for medicine release, including pyrogen, acute systemic toxicity and other tests.

Laboratory animals and Equipment

An agent and supplier based on research and development of animal experiments, providing import services for various disease model animals in research institutions.

 

麥德凱生科股份有限公司將於2023年Bio Asia亞洲生技大會上展示其最新服務範疇和產品解決方案。

該展會將於07月27日至07月30日在台北南港展覽館一館盛大開幕,Bio Asia做為國際生物科技領域的重要盛會,將有數百家生物科技企業參展。

麥德凱生科將展示一系列針對產品的臨床及臨床前試驗整合性服務,包括

 

  1. 新藥研發臨床前.臨床測試
  2. 藥品批次檢驗
  3. 醫療器材 ISO 10993生物相容性系列試驗
  4. 健康食品/非傳統性食品原料認證試驗及查驗登記輔導
  5. 健康食品/保健食品ODM及OEM
  6. 新/既有化學物質 物理化學特性.毒理.生態毒理.登錄等一站式服務
  7. 農藥及環境用藥 毒理.生態毒理試驗
  8. 醫療器材/保健食品/化妝品進出口服務
  9. 其他客製化試驗及檢測委託等。

 

除此之外,今年麥德凱生科將邀請株式会社 新日本科学 (SNBL)在日本的臨床前專業人士來台,展會期間歡迎各界研發專家到展場進行現場的交流和合作洽談。我們期待與相關領域的專家、潛在客戶和投資者分享近年在臨床及臨床前最新的研發成果。

 

麥德凱生科股份有限公司洪志駿總經理表示:「很榮幸能參加2023臺灣Bio Asia展會。這是一個絕佳的機會,讓我們展示在生科產業整合性服務並與各界專家交流。我們期待與展會參與者分享我們的使命和願景,並建立更多合作機會。」

 

聯繫方式:

麥德凱生科股份有限公司(展位:N802生技服務區)

電話:02-2625-3300

郵件:service@medgaea.com.tw

網站:https://www.medgaea.com.tw/